302
Participants
Start Date
April 7, 2017
Primary Completion Date
April 1, 2021
Study Completion Date
April 1, 2021
Isoniazid 300 Mg ORAL TABLET
The study intervention will include a single arm given (1) 6H: 300 mg INH daily by mouth for 6 months.
Pyridoxine 25 Mg Oral Tablet
All participants will also receive 25 mg pyridoxine (vitamin B-6) daily by mouth for 6 months for the treatment duration to reduce the risk of INH-induced peripheral neuropathy.
Mbarara University of Science and Technology/Mbarara Regional Referral Hospital, Mbarara
Collaborators (1)
Boston University
OTHER
Boston Medical Center
OTHER
Mbarara University of Science and Technology
OTHER
University of California, San Francisco
OTHER